Thursday, May 08, 2025 12:21:03 PM
"You don’t want to pump up an unapproved product or be accused of trying to influence any MHRA decision making, so quiet is safe!"
Quiet has gotten us to .25 a share.
This is the same cut and paste answer that is given every time someone says the company should be more vocal in what they are doing and have accomplished. Its always "you cant talk about an ongoing lawsuit and you dont want to piss off the MHRA"
I have given a few examples of things they can promote, patents, long tail survivor anniversaries, etc ..; however, that is not my job. They are lawyers, I am sure they can figure out some things that would interest potential stockholders.
So there IS a correlation between dilution and lower SP.
Imagine what would have happened if there was a PR after the 24% SP rise. Would that have kept the momentum up? We'll never know.
JMO
Quiet has gotten us to .25 a share.
This is the same cut and paste answer that is given every time someone says the company should be more vocal in what they are doing and have accomplished. Its always "you cant talk about an ongoing lawsuit and you dont want to piss off the MHRA"
I have given a few examples of things they can promote, patents, long tail survivor anniversaries, etc ..; however, that is not my job. They are lawyers, I am sure they can figure out some things that would interest potential stockholders.
So there IS a correlation between dilution and lower SP.
Imagine what would have happened if there was a PR after the 24% SP rise. Would that have kept the momentum up? We'll never know.
JMO
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
